I'm in both, though more comfortable with Nearmap.
Nearmap
Product offer is less complex, they're not selling a 'stack',
ROI is easy for many clients to calculate,
Australia has been profitable since FY2014.
USA launched FY2015, and tracking at double revenue of Australia at same time and accelerating (though costs higher).
Growth trajectory, break even is clear to see.
Only in Au, US and NZ, so opportunity is substantial. Narrow geographic focus is a plus, but plans to widen it.
New use cases appearing regularly.
Thanks for the prompt, it has been a useful exercise.
- Forums
- ASX - By Stock
- CAT
- Valuation Comparison
Valuation Comparison, page-3
-
- There are more pages in this discussion • 98 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CAT (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.42 |
Change
0.030(0.88%) |
Mkt cap ! $638.2M |
Open | High | Low | Value | Volume |
$3.41 | $3.51 | $3.34 | $5.142M | 1.509M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | $3.41 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.47 | 6413 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.980 |
1 | 4986 | 0.970 |
1 | 1036 | 0.965 |
2 | 32659 | 0.960 |
2 | 41512 | 0.940 |
Price($) | Vol. | No. |
---|---|---|
0.990 | 1 | 1 |
1.000 | 42518 | 3 |
1.010 | 10000 | 1 |
1.020 | 25000 | 1 |
1.040 | 18507 | 4 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
CAT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online